Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 12, 2026.
CompletedNCT07928765
Multiple Sclerosis, Relapsing-Remitting
Not applicable18 years - 65 yearsMersin, Mersin, Turkey (Türkiye) This single-group, mixed-methods study explored changes following a 13-week group psychodrama programme in adults with relapsing-remitting multiple sclerosis (MS). Participants were recruited from the demyelinating diseases unit of Mersin University …
CompletedNCT06129188
Anesthesia
Phase 118 years - 89 yearsBirmingham, Alabama, United States The objective of this proposal is to conduct a prospective randomized study comparing the utility of sedating patients undergoing transesophageal echocardiographic studies with a novel, recently-FDA-approved sedative agent, remimazolam, versus the se…
RecruitingNCT07070102
Pyelonephritis
Observational1 days - 15 yearsParis, Ap-hp / DRCI, France Temocillin, a 6-alpha-methoxypenicillin derivative of ticarcillin, is a narrow-spectrum antibiotic, primarily restricted to Enterobacterales. Therefore, its prescription for the treatment of febrile urinary tract infections requiring hospitalization …
Not yet recruitingNCT07929805
Chronic Hepaititis B
Phase 118 years - 65 yearsBeijing, China +3 This is a multicenter, randomized, open-label, parallel-controlled Phase Ib clinical trial. It aims to evaluate the safety and preliminary efficacy of ACT201 Injection combined with standard therapy (PegIFNα, NA) in participants with chronic hepatiti…
Active, not recruitingNCT04288427
Benign Prostatic Hyperplasia · Prostate Hyperplasia · Prostate Disease · Prostate Hypertrophy · Prostate Pain · Lower Urinary Tract Symptoms · Urinary Obstruction · Urinary Tract Disease
Not applicable50 years - Not specifiedBoston, Massachusetts, United States The study is being conducted to learn why some patients with Benign Prostatic Hyperplasia (BPH) do not respond to a commonly used treatment drug, Finasteride. The hope is to find ways to predict which patients will not respond to Finasteride so that,…
RecruitingNCT07570173
B-cell Acute Lymphoblastic Leukemia
Phase 2 / Phase 312 years - Not specifiedToronto, Ontario, Canada +26 Researchers are looking for new ways to treat people with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) that is CD19 positive using a medicine called MK-1045. MK-1045 is an immunotherapy, which is a treatment that helps the i…
RecruitingNCT06868485
Non Small Cell Lung Cancer
Phase 218 years - Not specifiedWeston, Florida, United States +14 This is a Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer whose Disease has Progressed with First-Line Osimertinib Treatment and whose Tumors harbor a C797S…
RecruitingNCT07926425
Visual Acuity
Observational18 years - Not specifiedRancho Cucamonga, California, United States The goal of this retrospective chart review is to evaluate the effectiveness of a 10MHz femtosecond laser utilized in performing wavefront-guided LASIK in a myopic population. Our hypothesis is that the outcomes will be as good as if not better than …
Not yet recruitingNCT07928076
Colorectal Cancer Postoperative Complications
Not applicable18 years - Not specifiedLocation not listed PRECAREX is a pilot randomized clinical trial with a two-arm parallel design aimed at evaluating the feasibility and safety of a preoperative weight loss intervention combining supervised exercise and calorie restriction in patients undergoing colore…
TerminatedNCT05116774
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 218 years - Not specifiedParis, France +6 The purpose of this study was to determine the efficacy and safety of BCX9930 monotherapy for the treatment of PNH compared to continued C5 inhibitor therapy in adult PNH participants with residual anemia despite treatment with a C5 inhibitor.
RecruitingNCT07778888
Dry Eye Disease
Phase 218 years - Not specifiedNewport Beach, California, United States Trial RX01-BL1107-1202 is designed to identify the lowest effective concentration of BL1107 required for complete resolution of conjunctival hyperemia in participants with DED. Participants will be masked to concentration of BL1107 received.
By invitationNCT06995885
Substance Use Disorders (SUDs)
Observational18 years - 99 yearsBaltimore, Maryland, United States Background: A Timeline Follow-Back (TLFB) is a tool that helps researchers track how much of a substance a person uses. Different versions of the tool are used to track the use of alcohol, cigarettes, and cannabis. But there is no TLFB to track a per…
Retrieved from ClinicalTrials.gov: Nov 12, 2026. Overall study status may differ from a particular location’s status.
